Cytomegalovirus retinitis
Information
- Disease name
- Cytomegalovirus retinitis
- Disease ID
- DOID:0080160
- Description
- "A retinitis that has_material_basis_in Cytomegalovirus." [url:https\://medlineplus.gov/ency/article/000665.htm]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00002330 | Completed | N/A | A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS | ||
| NCT00000134 | Completed | Phase 3 | Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT) | December 1992 | March 1995 |
| NCT00000135 | Completed | Phase 2/Phase 3 | Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT) | September 1995 | August 1996 |
| NCT00000136 | Completed | Phase 3 | Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) | March 1990 | October 1991 |
| NCT00000143 | Completed | Phase 3 | Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT) | May 1997 | June 2000 |
| NCT00000168 | Completed | Longitudinal Study of Ocular Complications of AIDS (LSOCA) | August 1998 | August 2013 | |
| NCT00000665 | Completed | N/A | Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component | ||
| NCT00000668 | Completed | Phase 1 | A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir | February 1995 | |
| NCT00000673 | Completed | Phase 1 | A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy | May 1993 | |
| NCT00000688 | Completed | Phase 3 | A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS | ||
| NCT00000691 | Completed | Phase 2 | A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure | August 1992 | |
| NCT00000693 | Completed | N/A | Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS | March 1992 | |
| NCT00004794 | Completed | Phase 2 | Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis | March 1995 | |
| NCT00005572 | Completed | A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) Infection | |||
| NCT00091884 | Completed | Efficacy of Elevated CD4 Counts on CMV Retinitis | July 2004 | April 2005 | |
| NCT01431326 | Completed | Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care | November 2011 | November 2019 | |
| NCT01866397 | Completed | Phase 4 | Pharmacokinetics of Cidofovir During Continuous Venovenous Hemofiltration | March 2002 | March 2002 |
| NCT04831333 | Completed | Deep Learning-based System and AIDS-related Cytomegalovirus Retinitis | April 1, 2021 | May 1, 2021 | |
| NCT00000698 | Completed | Phase 3 | A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis | August 2007 | |
| NCT00000726 | Completed | Phase 1 | Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome | February 1992 | |
| NCT00000766 | Completed | Phase 2 | CMV Retinitis Retreatment Trial | ||
| NCT00000799 | Completed | N/A | HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol | April 1996 | |
| NCT00000836 | Completed | Phase 2 | A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT) | August 1998 | |
| NCT00000894 | Completed | Phase 4 | Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis | ||
| NCT00000905 | Completed | A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV Therapy | |||
| NCT00000970 | Completed | Phase 1 | A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir | June 1993 | |
| NCT00000989 | Completed | N/A | The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS | July 1992 | |
| NCT00001034 | Completed | Phase 2 | The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV | August 1995 | |
| NCT00001061 | Completed | Phase 2 | Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS | March 1998 | |
| NCT00001062 | Completed | Phase 1 | A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes | January 1998 | |
| NCT00001611 | Completed | Immune Activity Against CVM Retinitis | February 1997 | April 2004 | |
| NCT00001999 | Completed | N/A | A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS | ||
| NCT00002015 | Completed | N/A | An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children | ||
| NCT00002016 | Completed | Phase 1 | A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis | ||
| NCT00002025 | Completed | N/A | Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient | ||
| NCT00002034 | Completed | N/A | A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS | ||
| NCT00002039 | Completed | N/A | An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients | ||
| NCT00002070 | Completed | Phase 3 | Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis | ||
| NCT00002125 | Completed | Phase 4 | A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium) | ||
| NCT00002134 | Completed | N/A | A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis | ||
| NCT00002135 | Completed | N/A | An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access | ||
| NCT00002142 | Completed | N/A | An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS | ||
| NCT00002156 | Completed | Phase 2 | A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR ) | ||
| NCT00002169 | Completed | Phase 2 | A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis | ||
| NCT00002187 | Completed | N/A | A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis | ||
| NCT00002222 | Completed | N/A | A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS | ||
| NCT00002247 | Completed | N/A | A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy | ||
| NCT00002257 | Completed | N/A | A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS | ||
| NCT00002299 | Completed | N/A | The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS | ||
| NCT00002321 | Completed | Phase 1 | A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis | ||
| NCT00000118 | Completed | Phase 3 | Ganciclovir Implant Study for Cytomegalovirus Retinitis | October 1992 | December 1993 |
| NCT00002355 | Completed | N/A | A Comparison of ISIS 2922 Used Immediately or Later in Patients With Cytomegalovirus (CMV) of the Eyes | ||
| NCT00002356 | Completed | Phase 2 | The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes | ||
| NCT00002377 | Completed | Phase 3 | A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes | January 1997 | December 2002 |
| NCT00002432 | Completed | N/A | A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS | ||
| NCT00002437 | Completed | Phase 2 | The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS | ||
| NCT05911503 | Recruiting | Early Phase 1 | Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis | July 1, 2023 | June 30, 2027 |
| NCT00002384 | Unknown status | N/A | A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS | ||
| NCT00002301 | Unknown status | N/A | A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir | ||
| NCT00017784 | Unknown status | Phase 3 | Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection | ||
| NCT00000697 | Withdrawn | Phase 2 | A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir | ||
| NCT00000881 | Withdrawn | Phase 1 | A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease |
- Disase is a (Disease Ontology)
- DOID:3612
- Cross Reference ID (Disease Ontology)
- GARD:9531
- Cross Reference ID (Disease Ontology)
- MESH:D017726
- Exact Synonym (Disease Ontology)
- CMV retinitis
- MeSH unique ID (MeSH (Medical Subject Headings))
- D017726